Northwest Biotherapeutics, Inc. Stock
Stocks
NWBO
US66737P6007
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2050 USD | +0.49% |
|
+19.39% | -10.40% |
| Market Cap | 277M 241M 224M 206M 388M 26.43B 394M 2.64B 1.04B 13.16B 1.04B 1.02B 44.12B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 373M 324M 302M 277M 523M 35.6B 531M 3.56B 1.4B 17.72B 1.4B 1.37B 59.43B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 10.3x |
| Free-Float |
95.04% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.49% | ||
| 1 week | +19.39% | ||
| Current month | +25.00% | ||
| 1 month | +10.69% | ||
| 3 months | +2.86% | ||
| 6 months | -29.55% | ||
| Current year | -10.40% |
| 1 week | 0.16 |  | 0.21 |
| 1 month | 0.14 | | 0.21 |
| Current year | 0.14 | | 0.34 |
| 1 year | 0.14 | | 0.37 |
| 3 years | 0.14 | | 1.09 |
| 5 years | 0.14 | | 2.05 |
| 10 years | 0.14 | | 2.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alton Boynton
CEO | Chief Executive Officer | 82 | 01/06/2007 |
Linda Powers
CEO | Chief Executive Officer | 71 | 08/06/2011 |
Marnix Bosch
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/01/2000 |
| Director | Title | Age | Since |
|---|---|---|---|
Alton Boynton
BRD | Director/Board Member | 82 | 01/01/1998 |
Linda Powers
CHM | Chairman | 71 | 17/05/2007 |
Navid Malik
BRD | Director/Board Member | 57 | 01/04/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 29/8/24 | Don | Founder | 1,000,000 | 0.0826% | ||
| 9/8/24 | Don | Chief Technology Officer | 3,000,000 | 0.2478% | ||
| 8/8/24 | Don | Founder | 1,000,000 | 0.0826% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.49% | +19.39% | -19.54% | -59.80% | 277M | |
| +2.35% | +2.74% | +38.10% | +74.02% | 56.54B | |
| -0.21% | -7.38% | +27.52% | +63.59% | 53.6B | |
| -2.44% | +1.40% | -15.61% | -13.72% | 22.91B | |
| -2.85% | -7.78% | -9.28% | +352.92% | 21.37B | |
| +2.49% | -0.92% | +23.57% | -11.65% | 20.27B | |
| +0.79% | -1.06% | +33.99% | -30.63% | 17.56B | |
| +0.58% | -5.88% | +19.40% | +572.88% | 14.75B | |
| +3.41% | -6.61% | +162.81% | +287.77% | 13.53B | |
| -5.25% | -4.23% | +42.32% | +160.72% | 13.33B | |
| Average | -0.06% | -3.41% | +30.33% | +139.61% | 23.41B | |
| Weighted average by Cap. | +0.23% | -2.96% | +30.73% | +121.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 38.93M 33.85M 31.5M 28.92M 54.62M 3.72B 55.47M 371M 146M 1.85B 146M 143M 6.2B |
| Net income | - | - |
| Net Debt | 96.08M 83.52M 77.74M 71.38M 135M 9.17B 137M 916M 360M 4.57B 361M 353M 15.31B | 125M 109M 101M 92.81M 175M 11.93B 178M 1.19B 468M 5.94B 469M 459M 19.91B |
Employees
105
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | US$0.1640 | -0.61% | 1,261,005 |
| 30/07/26 | US$0.1650 | +1.85% | 2,011,696 |
| 29/07/26 | US$0.1620 | -5.48% | 2,303,171 |
| 28/07/26 | US$0.1714 | -1.27% | 2,167,426 |
| 27/07/26 | US$0.1736 | +1.12% | 1,709,184 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1640USD
Average target price
1.000USD
Spread / Average Target
+509.76%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- NWBO Stock
Select your edition
All financial news and data tailored to specific country editions
